Division of Prison Health, Geneva University Hospitals, University of Geneva, Chemin de Champ-Dollon 22, 1241 Puplinge, Geneva, Switzerland.
Australian Centre for Public and Population Health Research, Faculty of Health, University of Technology, Sydney, Australia.
BMC Infect Dis. 2018 Oct 29;18(1):539. doi: 10.1186/s12879-018-3445-6.
Incarcerated people carry a high burden of infection, including blood-borne diseases (BBDs). It is also known that one million people contract a sexually transmitted infection (STI) every day worldwide, which represents a global public health challenge. However, data regarding the prevalence of STIs and the risk factors among incarcerated populations are lacking. The objective of this study was to determine the prevalence and associated factors of BBDs and STIs among detainees in the largest pre-trial prison in Switzerland.
In a cross-sectional study conducted at the Champ-Dollon pre-trial prison, 273 male detainees answered a standardized questionnaire and were screened for syphilis, herpes simplex virus 2 (HSV-2), HIV, and hepatitis C (HCV). Prevalence rates and associations of BBDs and STIs with risk factors were computed.
Most participants (90.9%) were migrants from outside Western Europe, and 5.9% were injecting drug users. HCV was diagnosed among 6.2% of participants (antibody prevalence). The prevalence of HCV was higher among injecting drug users (81.2%) than non-injectors (1.6%). The prevalence of HIV, syphilis, and HSV-2 was 0.4%, 1.1%, and 22.4%, respectively. HCV was associated with a history of injecting drug use and HSV-2 with a lower education level and being older than 26 years.
This study showed the infection prevalence of 2-9 times higher among detainees than in the Swiss community. It also illustrated that these infections are associated with sociodemographic and risk factors. Therefore, the prison environment offers an opportunity to strengthen infectious disease control programs targeting specific subgroups of at-risk people. Such programs would benefit both the prison population and broader society.
被监禁者感染负担沉重,包括血源性病原体(BBD)。全世界每天有 100 万人感染性传播感染(STI),这是一个全球性的公共卫生挑战。然而,关于被监禁人群中 STI 的流行率和风险因素的数据却很缺乏。本研究的目的是确定瑞士最大审前监狱中被拘留者的 BBD 和 STI 的流行率及相关因素。
在 Champ-Dollon 审前监狱进行的一项横断面研究中,273 名男性被拘留者回答了一份标准化问卷,并接受了梅毒、单纯疱疹病毒 2(HSV-2)、HIV 和丙型肝炎(HCV)的筛查。计算了 BBD 和 STI 的流行率和与风险因素的关联。
大多数参与者(90.9%)是来自西欧以外的移民,5.9%是注射吸毒者。6.2%的参与者(抗体流行率)被诊断为 HCV。注射吸毒者(81.2%)的 HCV 患病率高于非注射吸毒者(1.6%)。HIV、梅毒和 HSV-2 的患病率分别为 0.4%、1.1%和 22.4%。HCV 与注射吸毒史有关,HSV-2 与教育程度较低和年龄大于 26 岁有关。
本研究表明,被拘留者的感染流行率比瑞士社区高 2-9 倍。它还表明,这些感染与社会人口统计学和风险因素有关。因此,监狱环境为加强针对高危人群的传染病控制计划提供了机会。这些计划将使监狱人口和更广泛的社会受益。